Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

NCT07115446 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: HS-20093
DRUG: HRS-5041

Sponsor

Hansoh BioMedical R&D Company